Discounted Cash Flow
Amgen Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $23.0b | $7.7b | $9.6b | 33.6% | $10.32 |
| 2017 | $22.8b (-0.6%) | $2.0b (-74.4%) | $10.5b (9.3%) | 8.7% (-74.2%) | $2.71 (-73.7%) |
| 2018 | $23.7b (3.9%) | $8.4b (324.2%) | $10.6b (0.4%) | 35.3% (308.1%) | $12.70 (368.6%) |
| 2019 | $23.4b (-1.6%) | $7.8b (-6.6%) | $8.5b (-19.2%) | 33.6% (-5.0%) | $12.96 (2.0%) |
| 2020 | $25.4b (8.8%) | $7.3b (-7.4%) | $9.9b (15.9%) | 28.6% (-14.9%) | $12.40 (-4.3%) |
| 2021 | $26.0b (2.2%) | $5.9b (-18.9%) | $8.4b (-15.2%) | 22.7% (-20.6%) | $10.34 (-16.6%) |
| 2022 | $26.3b (1.3%) | $6.6b (11.2%) | $8.8b (4.8%) | 24.9% (9.7%) | $12.18 (17.8%) |
| 2023 | $28.2b (7.1%) | $6.7b (2.5%) | $7.4b (-16.2%) | 23.8% (-4.3%) | $12.56 (3.1%) |
| 2024 | $33.4b (18.6%) | $4.1b (-39.1%) | $10.4b (41.2%) | 12.2% (-48.6%) | $7.62 (-39.3%) |
| 2025 | $36.8b (10.0%) | $7.7b (88.5%) | $8.1b (-22.1%) | 21.0% (71.5%) | $14.33 (88.1%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.